BlueWillow Biologics, Inc. Employee Directory
Biotechnology ResearchUnited States11-50 Employees
BlueWillow Biologics, Inc. is a United States-based biotechnology research company focused on developing intranasal vaccines and adjuvants. Its approach aims to stimulate mucosal immunity in the nasal passages while also eliciting systemic immune responses, with a pipeline including Peanut Allergy, HSV-2, Covid-19, Anthrax, Pandemic Flu and RSV. The organization operates at the clinical stage, pursuing safe and effective nasal vaccines to address global health challenges. In 2022 the company was acquired by LimeWire GmbH. Based in the United States and active in biotechnology research, BlueWillow targets protection from respiratory infections, sexually transmitted diseases, and food allergies through its intranasal vaccine programs.